drugset / Trial / NCT02762474

Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer

NCT02762474 ↗

NaSingle-groupOpen-labelTreatment

Summary

This trial is going to evaluate the efficacy and safety of IMRT / nab-TP chemotherapy for unresectable esophageal cancer, and to investigate the optimal concurrent chemotherapy regimen for local advanced and unresectable esophageal cancer patients.

Timeline

Start
2014-07
Primary completion
2017-11
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Nab-paclitaxel Small molecule — —

Indications